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Elongation factor 2 (EF-2) from eukaryotes and archaebacteria can be ADP-ribosylated by diphtheria toxin 
(DT) [(1977) Annu. Rev. Biochem. 46, 69-94; (1980) Nature 287, 250-2511. The primary structure of the 
ADP-ribose accepting region in EFs from the archaebacteria Thermoplasma acidophilum, Halobacterium cu- 
tirubrum and Methanococcus vannielli was determined in order to elucidate the degree of conservation com- 
pared with 4 previously established eukaryotic sequences [(1971) FEBS Lett. 103, 253-2551. Within a 9- 
residue sequence including the site of ADP-ribosylation 5 positions were found to be occupied by the same 
amino acid in all the archaebacterial and eukaryotic factors studied. There were more differences among 
the 3 archaebacterial sequences than among the 4 eukaryotic ones. 
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1. INTRODUCTION 
Eukaryotic elongation factor 2 (EF-2) which 
catalyzes translocation of peptidyl-tRNA and 
mRNA on the ribosome, can be ADP-ribosylated 
by fragment A of diphtheria toxin (DT) [ 11, in con- 
trast to the analogous prokaryotic factor EF-G [4]. 
The ADP-ribose accepting moiety of EF-2 is the 
novel, weakly basic amino acid ‘diphthamide’ 
isolated from yeast EF-2 and identified as a post- 
translationally modified histidine [5,6]. Digestion 
of EF-2 from phylogenetically distant eukaryotic 
sources yielded peptides with a conserved sequence 
over a stretch of 11 amino acids in which diph- 
thamide occupied the position penultimate to the 
C-terminus [3,7,8]. 
Just like eukaryotes, all members of the archae- 
bacterial kingdom [9] so far studied contain a pro- 
* To thorn correspondence should be addressed 
tein which can serve as substrate for the catalytic 
action of DT [2,10]. We isolated this protein and 
identified it as translocating elongation factor in 3 
archaebacterial species, the extremely halophilic 
Halobacterium cutirubrum, the methanogenic 
Methanococcus vannielii and the thermoacido- 
philic Thermoplasma cidophilum [ 11,121. Amino 
acid analysis of the total postribosomal superna- 
tant proteins from H. halobium grown with 
[3H]histidine provided evidence for diphthamide 
or its deamidation product diphthine being part of 
some halobacterial protein, presumably of an elon- 
gation factor [13]. 
To establish whether the ADP-ribose accepting 
sequence in eukaryotic EF-2 has an evolutionary 
precursor in common with the sequence in the ar- 
chaebacterial factors, we cleaved ADP-ribosyl- 
EF-2 from the 3 species mentioned, purified the 
labelled peptides and sequenced them. We found a 
remarkably high degree of conservation between 
archaebacterial and eukaryotic sequences. 
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2. EXPERIMENTAL 
2.1. Partially purified elongation factors 
EF-2 from H. cutirubrum Cz.Col1.M. 2088 was 
prepared as described [ll]. Purification pro- 
cedures for EF-2 from A4. vannielii DSM 1224 and 
T. acidophilum DSM 1728 will be published 
elsewhere in detail; the main steps are summarized 
in the flow scheme (fig.1). 
2.2. ADP-ribosylation 
H. cutirubrum: 10 ml Tris-HCl buffer, pH 7.6, 
contained 5-20 nmol EF-2, 70pmol mercap- 
toethanol, 28.2 mmol KCl, 900 flocculation units 
of DT (Behring) preincubated with 12.5 mM mer- 
captoethanol, and 141 nmol [14C]NAD (Amer- 
sham), spec. act. 4.84 mCi/mmol; incubation for 
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Fig. 1. Flow scheme for the isolation of ADP-ribosylated 
peptides from non-halophilic archaebacterial post- 
ribosomal supernatants. For H. cutirubrum, the peptide 
isolation procedure, beginning with ‘ADP-ribosyl- 
EF-2’, was the same; for EF-2 isolation see [ll]. 
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16 h at 37°C. With non-halophilic factors, 200 
nmol KCI, 500 flocculation units of DT and 30 min 
incubation time were applied leaving the other con- 
ditions unchanged. After labelling protein was 
precipitated with trichloroacetic acid, washed and 
lyophilized. 
2.3. Proteolytic cleavage 
1 mg dried protein in 1 ml of 1% ammonium 
hydrogen carbonate was incubated with 50,~g 
trypsin (Merck, TPCK-treated) for 5 h or longer 
periods of time (see section 3) at room temper- 
ature, or in 1 ml of 1% sodium hydrogen car- 
bonate with 2Opg proteinase Arg C (Boehringer) 
for 24 h at 37°C. 
2.4. Affinity chromatography 
After proteolysis the peptide mixture was ap- 
plied to a column (10 x 90 mm) of dihydrox- 
yborylacrylamide (Affi-gel 601, Bio-Rad) equili- 
brated with 0.25 M ammonium acetate, pH 8.2, 
and washed with 30 ml of this buffer. The ad- 
sorbed material was eluted with 0.1 M ammonium 
acetate, pH 5.2. “C-labelled fractions were col- 
lected and rechromatographed in the same manner 
or concentrated by freeze-drying, transferred into 
ammonium hydrogen carbonate by gel filtration 
(Sephadex G-15 or G-25, Pharmacia) and desalted 
by repeated freeze-drying. 
2.5. Gel filtration 
A Sephadex G-25 column (14 x 60 mm) equili- 
brated with 0.01 M ammonium hydrogen car- 
bonate was used. 
2.6. High-performance liquid chromatography 
The ADP-ribosyl peptides were further purified 
by reversed-phase chromatography on a Pep RPC 
5/5 column, 5 x 50 mm (Pharmacia FPLC system; 
for details see fig.2 legend); in several experiments, 
a Vydac TP RPlO, 4.6 x 250 mm (Chrompack), 
column was used in a Hewlett-Packard HPLC 
system. 
2.7. Total amino acid analysis 
The samples were hydrolyzed with 200~1 of 
5.7 M HCl at 110°C for 20 h. For determination a 
Biotronik amino acid analyser with a single col- 
umn system was employed. 
Volume 185, number 1 FEBS LETTERS June 1985 
2.8. End group analysis 
0.2-l .O nmol of ADP-ribosyl peptide were dan- 
sylated [ 141 and hydrolyzed in 6 M HCl at 105°C 
for 16 h. Dansyl-amino acid analysis was per- 
formed by thin-layer chromatography [15]. 
2.9. Amino acid sequence analysis 
For the Edman degradation [16] a prototype se- 
quenator was used. Samples (about 2 nmol) were 
sequenced in the presence of 1 mg polybrene [ 171. 
The phenylhydantoin derivatives of the amino 
acids were analyzed by an isocratic HPLC system 
[181. 
2.10. Radioactivity measurement 
A Packard Tri-Carb Liquid scintillation spec- 
trometer was used. Labelled peptides were directly 
added to Quickscint 212 (Zinsser) and counted, 
radioactive proteins after precipitation on glass 
fiber filters. 
3. RESULTS 
After 3 repeats of the affinity chromatography 
procedure nearly pure ADP-ribosyl peptides were 
obtained from ADP-ribosyl-EF-2 digested with 
trypsin for 5 h and with arginine-specific protease 
for 24 h. When analyzing the factors from T. 
acidophilum and H. cutirubrum, high-perfor- 
mance liquid chromatography yielded only one 
major peak (fig.2, peaks A and B) containing 
about 75% of the r4C label applied to the column. 
Gel filtration on Sephadex G-25 indicated A4, 
values to be roughly 2000. End group analysis 
showed only dansyl-leucine. The two peptides had 
nearly the same amino acid composition except 
that serine found in the Thermoplasma peptide 
was replaced by alanine in Halobacterium (table 
1). By automated Edman degradation the follow- 
ing sequences were established: 
Fig.2. High-performance liquid chromatography of 
tryptic ADP-ribosyl peptides isolated with Affi-gel 601 
(see section 2). Solvent A, water; solvent B, 0.1% 
trifluoroacetic acid in acetonitrile (v/v). A linear 
gradient (below) between 0 and 15% B in 45 min was 
employed; flow rate 0.7 ml/min. Detector adjusted to 
0.5 absorption units full scale at 214 nm. Sample 
amount about 1.5-2 nmol each. 
T. acidophilum: Leu-His-Glu-Asp-Ser-Be-[gap]-Arg 
H. cutirubrum: Leu-His-Glu-Asp-Ala-Be-[gap]-Arg 
In the case of Methanococcus EF-2, incubation 
with trypsin for at least 18 h was required to obtain 
amounts of ADP-ribosylpeptide sufficient for 
analysis. The material eluted from the affinity col- 
umn could be separated by gel filtration and by 
HPLC analysis into two peaks; the one running 
faster through Sephadex G-25 was eluted from the 
reversed-phase column after a much longer reten- 
tion time than the other (fig.2, peaks C and D). 
Both peaks together contained about 75% of the 
added r4C label. As the time of digestion was in- 
creased the relative amount of the higher-M, com- 
pound decreased. 
For the penultimate positions of the sequences, the End group determination again showed leucine 
sequenator produced no amino acid derivative at for peak D but histidine for C; amino acid analysis 
all (as symbolized by ‘gap’) probably due to the (table 1) indicated peptide D to be 6 residues longer 
high polarity of ADP-ribosyl-substituted diph- than C corresponding with the results obtained by 
thamide or diphthine. sequence analysis: 
39 
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Table 1 
Amino acid composition of ADP-ribosyl peptides isolated by HPLC 
Amino acid Peptide from 
T. acidophilum H. cutirubrum 
(fig.2, (peak B) 
peak A) 
M. vannielii 












0.9 (1) 1.0 (1) 
_ _ _ _ 
0.8 (1) - - 
1.1 (1) 1.1 (1) 
0.7 - 1.1 - 
_ _ 0.9 (1) 
0.6 (1) 0.7 (1) 
0.9 (1) 0.8 (1) 
_ _ _ _ 
0.9 (1) 0.9 (1) 
0.9 (1) 0.9 (1) 
1.1 (1) 1.9 (2) 
_ _ 1.0 (1) 
_ _ _ 
1.1 (1) 1.1 (1) 
0.9 - 1.0 - 
0.9 (1) 1.7 (2) 
0.8 (1) 1.3 (2) 
_ _ 1.0 (1) 
_ _ 0.9 (1) 
0.9 (1) 1.0 (1) 
0.8 (1) 0.9 (1) 
Totalb 7 7 6 12 
A Glycine is formed from adenine in the ADP-ribose side chain [3,19] 
b The modified histidine residue is not included; an additional peak eluted between Phe 
and His probably represented diphthine [7]; the amido group of diphthamide and the 
ADP-ribose residue are split off under the conditions of acid hydrolysis [6] 
Numbers represent mol residues per mol peptide as determined by amino acid analysis 








The differences in chromatographic retention 
times between the 4 peptides (fig.2) are in good 
agreement with the sequence differences. 
4. DISCUSSION 
Isolation of ADP-ribosylpeptides from tryptic 
digests based on the affinity of the ribose moieties 
to dihydroxyboryl groups results in only one pep- 
tide thus giving evidence that the archaebacterial 
elongation factors studied contain only one ADP- 
ribosylation site. This holds true also for the 
Methanococcus factor; of the two labelled peptides 
40 
(fig.2, peaks C and D) the smaller one (C) is ob- 
viously generated from the larger peptide by 
hydrolysis of a trypsin-sensitive phenylalanyl- 
histidine bond. 
It seems highly probable that the ADP-ribo- 
sylated residue is in the penultimate position in 
which gaps appeared instead of phenylthiohydan- 
toin amino acids during the sequencing procedure. 
The presumption that the novel amino acid diph- 
thamide (or diphthine, see below) may be the 
ADP-ribose acceptor is corroborated by the se- 
quence similarity between the ADP-ribose accep- 
ting sites of the 3 archaebacteria and those of the 
eukaryotic factors so far studied [3] in which 
diphthamide occupies the corresponding position 
(fig.3). 
Arginine-specific protease produced the same 
peptides from the Halobacterium and Thermo- 
plasma factors as trypsin did; hence, before 
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Fig.3. Primary structure at the sites of ADP-ribosylation 
in archaebacterial EF-2s compared with eukaryotic 
EF-2s (eukaryotic sequences from [3]). Dip, 
diphthamide (clearly established for yeast) or diphthine. 
cleavage the N-terminal leucine most likely had 
been preceded by arginine. 
Within the g-residue sequence which has been 
established in all the 7 factors analyzed (positions 
5-13 in fig.3), 7 amino acids are conserved from 
Halobacterium and Methanococcus to eukaryotes, 
the Thermoplasma sequence showing one addi- 
tional exchange in position 10. An invariable 
aspartate is located in that part of the eukaryotic 
and methano~o~~al sequences which is still un- 
known in the cases of Thermopfasma and 
Halobacterium. 
Although the number of species and sequence 
positions compared is too small to draw definitive 
conclusions, there are, remarkably, a larger num- 
ber of differences among the 3 ar~haebacteria than 
between eukaryotes as phylogenetically distant as 
yeast and mammals. Only one amino acid, Clu in 
position 8, may be specific for the archaebacterial 
sequences. 
Considering a possible influence of the sequence 
differences on diphtheria toxin catalysis, the ques- 
tion arises as to whether the far slower rate of the 
toxin reaction with archaebacterial factors than 
with eukaryotic ones [13,21] may be connected 
with the charged amino acids Glu (position 8) and 
Arg (position 5). Interestingly, ~etha~ococcffs 
EF-2 having Thr Iike the eukaryotic factors instead 
of Arg reacts somewhat faster with DT than Ther- 
mopfasma does (R. Gehrmann, unpublished). On 
the other hand, it is not yet established whether 
diphthine, as detected in H. halobium cell protein 
113,221, or its amide, diphthamide, as found in 
eukaryotes, is the real ADP-ribose acceptor in ar- 
chaebacterial EF-2. Elongation factor from mu- 
tant eukaryotic cells containing diphthine was 
ADP-ribosylated at a greatly reduced rate com- 
pared with wild-type EF-2 [22J. 
The physiological role of the diphthamide con- 
taining domain which may explain why its se- 
quence has been conserved over at least two billion 
years is not definitely known, but there are indica- 
tions that EF-2 serves as a substrate for a cellular 
ADP-ribosyltransferase acting in a similar way to 
diphtheria toxin [23,24]. Since the enzymatic effect 
of EF-2 is inhibited by ADP-ribosylation the do- 
main common to eukaryotes and archaebacteria 
may play a part in a novel translational regulation 
mechanism. Whether the conserved sequence may 
be directly involved in such a mechanism or is only 
needed as a recognition region for the diphthamide 
synthesizing enzymes remains to be clarified. 
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